Three patients continue to show improvements in BCVA 3 years post-treatment. Interim results from an ongoing phase 1/2a clinical study (NCT02286089) evaluating OpRegen support the treatment’s efficacy in patients with dry age-related macular degeneration (AMD) with geographic atrophy (GA). Investigators found that 83% (10/12) of a cohort of treated patients continued to exhibit stable or improved Best […]

Dr. Charles “Chuck” Fisher Jr. has so many terrific insights. You will be riveted as he discusses his time as a special operations leader in Iraq where he had two direct hits to the chest by high caliber bullets. Then how he later met the man who developed the very body armor that saved his […]

FDA is walking back the contraindication against statins for pregnant patients, but the agency maintains that most pregnant people should stop statin therapy. Rates of venous thromboembolism after elective total knee arthroplasty favored the novel factor XI inhibitor abelacimab over standard anticoagulant enoxaparin (Lovenox) in a phase II trial. (New England Journal of Medicine)